Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://pediatrics.aappublications.org/cgi/content/abstract/111/6/1289

Pediatrics AAP Grand Rounds
Home Help [Feedback] [For Subscribers] [Browse & Search]


Full Text of this Article
Reprint (PDF) Version of this Article
Email this article to a friend
P3Rs: Submit a response to this article
Similar articles found in:
Pediatrics Online
PubMed
PubMed Citation
This Article has been cited by:
other online articles
Search PubMed for articles by:
Zhou, F. || Mock, J.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Infectious Disease & Immunity
 
Related AAP Red Book topics:
    Hepatitis B
 


PEDIATRICS Vol. 111 No. 6 June 2003, pp. 1289-1296

 

Economic Analysis of Promotion of Hepatitis B Vaccinations Among Vietnamese-American Children and Adolescents in Houston and Dallas

Fangjun Zhou, MS, PhD*, Gary L. Euler, MPH, DrPH*, Stephen J. McPhee, MD{ddagger}, Thoa Nguyen{ddagger}, Tram Lam, BS{ddagger}, Ching Wong, BS{ddagger} and Jeremiah Mock, MSc, PhD{ddagger}

 

* National Immunization Program, CDC, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia
{ddagger} Suc Khoe La Vang! (Health is Gold), the VCHPP, Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California

Objective. To ascertain the cost-effectiveness and benefit-cost ratios of 2 public health campaigns conducted in Dallas and Houston in 1998–2000 for "catch-up" hepatitis B vaccination of Vietnamese-Americans born 1984–1993.

Design. Program evaluation.

Setting. Houston and Dallas, Texas.

Participants. A total of 14 349 Vietnamese-American children and adolescents.

Interventions. Media-led information and education campaign in Houston, and community mobilization strategy in Dallas. Outcomes were compared with a control site: Washington, DC.

Main outcome measures. Receipt of 1, 2, or 3 doses of hepatitis B vaccine before and after the interventions, costs of interventions, cost-effectiveness ratios for intermediate outcomes, intervention cost per discounted year of life saved, and benefit-cost ratio of the interventions.

Results. The number of children who completed the series of 3 hepatitis B vaccine doses increased by 1176 at a total cost of $313 904 for media intervention, and by 390 and at $169 561 for community mobilization. Costs per child receiving any dose, per dose, and per completed series were $363, $101, and $267 for media intervention and $387, $136, and $434 for community mobilization, respectively. For media intervention, the intervention cost per discounted year of life saved was $9954 and 131 years of life were saved; for community mobilization, estimates were $11 759 and 60 years of life. The benefit-cost ratio was 5.26:1 for media intervention and 4.47:1 for community mobilization.

Conclusion. Although the increases in the number of children who completed series of 3 doses were modest for both the Houston and Dallas areas, both media education and, to a lesser degree, community mobilization interventions proved cost-effective and cost-beneficial.

 

Key Words: cost-effectiveness analysis • benefit-cost analysis • hepatitis B vaccination • media education • community mobilization • Vietnamese-Americans

 

Abbreviations: HBV, hepatitis B virus • HepB, hepatitis B vaccine • VFC, Vaccines for Children • ACIP, Advisory Committee on Immunization Practices • CDC, Centers for Disease Control and Prevention • API, Asian and Pacific Islander • VCHPP, Vietnamese Community Health Promotion Project • CE, cost-effectiveness

 


Received for publication Aug 8, 2002; accepted Nov 20, 2002.


This article has been cited by other articles:

 


 
Home page
 
PediatricsHome page
S. J. McPhee, T. Nguyen, G. L. Euler, J. Mock, C. Wong, T. Lam, W. Nguyen, S. Nguyen, M. Q. Huynh Ha, S. T. Do, and C. Buu
Successful Promotion of Hepatitis B Vaccinations Among Vietnamese-American Children Ages 3 to 18: Results of a Controlled Trial
Pediatrics, June 1, 2003; 111(6): 1278 - 1288.
[Abstract] [Full Text] [PDF]

 

[For Subscribers]
Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.